Bell & Brown Wealth Advisors’s Gilead Sciences GILD Stock Holding History

Bell & Brown Wealth Advisors’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-2,965	Closed	-$207K	–	73
2021 Q3	$207K	Buy	+2,965	New	+$208K	0.11%	69
2020 Q1	–	Sell	-15,693	Closed	-$1.01M	–	73
2019 Q4	$1.01M	Sell	15,693 -2,485	-14%	-$162K	0.75%	52
2019 Q3	$1.15M	Sell	18,178 -974	-5%	-$63.7K	0.94%	44
2019 Q2	$1.29M	Buy	19,152 +191	+1%	+$12.6K	1.14%	37
2019 Q1	$1.23M	Sell	18,961 -280	-1%	-$18.6K	1.12%	38
2018 Q4	$1.2M	Sell	19,241 -2,015	-9%	-$141K	1.29%	31
2018 Q3	$1.45M	Buy	21,256 +840	+4%	+$63.4K	1.35%	29
2018 Q2	$1.45M	Buy	20,416 +1,731	+9%	+$122K	1.43%	28
2018 Q1	$1.35M	Sell	18,685 -25	-0.1%	-$1.99K	1.43%	29
2017 Q4	$1.34M	Buy	+18,710	New	+$1.42M	1.39%	30

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bell & Brown Wealth Advisors's GILD Position: Q4 2021 in Review

Bell & Brown Wealth Advisors sold out of Gilead Sciences (GILD) in Q4 2021, closing a stake of 2,965 shares — an estimated $207K sold.

Bell & Brown Wealth Advisors first reported a position in GILD in Q4 2017 and held it in 10 quarters. The position peaked at $1.45M in Q3 2018. 1,682 funds tracked by Wall St. Rank hold GILD as of Q4 2021.

Bell & Brown Wealth Advisors reported no remaining Gilead Sciences position as of Q4 2021 after selling out during the quarter.
Bell & Brown Wealth Advisors sold 2,965 Gilead Sciences shares in Q4 2021, an estimated $207K.
Bell & Brown Wealth Advisors first reported a position in Gilead Sciences in Q4 2017 and held it in 10 quarters.
Bell & Brown Wealth Advisors's Gilead Sciences position peaked at $1.45M in Q3 2018.
1,682 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2021.

Based on Bell & Brown Wealth Advisors's 13F filing for Q4 2021, filed 10 Feb 2022.